statistiche ricercatore

Continente	#
NA - Nord America	1.007
EU - Europa	679
AS - Asia	599
SA - Sud America	113
Continente sconosciuto - Info sul continente non disponibili	20
AF - Africa	11
OC - Oceania	4
Totale	2.433

Nazione	#
US - Stati Uniti d'America	978
DE - Germania	187
SG - Singapore	187
CN - Cina	171
SE - Svezia	118
VN - Vietnam	110
PL - Polonia	100
BR - Brasile	90
IT - Italia	64
FR - Francia	42
GB - Regno Unito	37
UA - Ucraina	34
IE - Irlanda	24
ID - Indonesia	18
IN - India	18
FI - Finlandia	17
BE - Belgio	15
HK - Hong Kong	15
TR - Turchia	14
CA - Canada	11
BD - Bangladesh	8
JP - Giappone	8
RU - Federazione Russa	8
AR - Argentina	7
MX - Messico	7
SA - Arabia Saudita	7
CO - Colombia	6
ES - Italia	5
IL - Israele	5
KR - Corea	5
AU - Australia	4
IQ - Iraq	4
IR - Iran	4
JO - Giordania	4
LT - Lituania	4
NL - Olanda	4
PK - Pakistan	4
PT - Portogallo	4
ZA - Sudafrica	4
CL - Cile	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
BO - Bolivia	2
CH - Svizzera	2
EC - Ecuador	2
IM - Isola di Man	2
LV - Lettonia	2
PA - Panama	2
RO - Romania	2
TH - Thailandia	2
TW - Taiwan	2
AG - Antigua e Barbuda	1
AL - Albania	1
AO - Angola	1
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BS - Bahamas	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EE - Estonia	1
GE - Georgia	1
GF - Guiana Francese	1
GP - Guadalupe	1
JM - Giamaica	1
KE - Kenya	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
MK - Macedonia	1
MY - Malesia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PS - Palestinian Territory	1
SK - Slovacchia (Repubblica Slovacca)	1
SO - Somalia	1
TJ - Tagikistan	1
TN - Tunisia	1
UG - Uganda	1
VC - Saint Vincent e Grenadine	1
VE - Venezuela	1
VI - Stati Uniti Isole Vergini	1
Totale	2.413

Nome	#
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD	358
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	248
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	201
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	192
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	190
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	189
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD	175
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases	174
Investigational prostaglandin D2 receptor antagonists for airway inflammation	174
Dupilumab for the treatment of asthma	164
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	140
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	124
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis	104
Totale	2.433

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	123	0	0	0	25	8	3	4	20	6	11	22	24
2022/2023	338	44	52	20	60	32	34	12	25	47	2	6	4
2023/2024	135	9	40	3	14	8	23	13	1	0	4	11	9
2024/2025	249	6	10	17	16	33	11	14	4	29	18	52	39
2025/2026	673	102	24	26	47	116	38	161	28	48	53	15	15
2026/2027	111	22	9	42	38	0	0	0	0	0	0	0	0
Totale													2.433

IRIS UniCatt